Non-disclosure and confidentiality agreements in the psychedelic space

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

Who this is for: Oregon and Colorado operators, founders, employees, investors, and supply partners who use confidentiality agreements, the lawyers who draft them, and participants who are asked to sign one.

The short answer

A non-disclosure agreement, or confidentiality agreement, binds a party not to disclose or misuse another party’s confidential business information. Psychedelic businesses use them with investors, employees, contractors, and supply partners to protect trade secrets, financials, and proprietary methods. An NDA has standard limits: it cannot cover information that is already public, and it cannot bar someone from reporting a violation to a regulator or from complying with a court order. Two points are specific to this field: a confidentiality agreement among businesses is not the document that protects a participant’s personal and health information, and an NDA cannot be used to silence a participant from reporting harm.

What a confidentiality agreement does

An NDA defines what counts as confidential information, who can receive it, how it may be used, and how long the obligation lasts. It can be mutual, where both sides share and protect information, or one-way, where one side discloses and the other protects. It usually requires the receiving party to return or destroy the information when the relationship ends, and it sets the remedies for a breach, which often include an injunction because money alone may not undo a disclosure. The agreement is only as strong as its definitions and its scope; an NDA that tries to cover everything indefinitely is harder to enforce than one that protects identified information for a reasonable period.

Where psychedelic businesses use them

Confidentiality agreements appear at most points where a psychedelic business shares sensitive information. A business negotiating with investors uses one to protect its financials and plans; Investor agreements and capitalization for psychedelic businesses covers that setting. Employees and contractors, including facilitators, sign confidentiality terms as part of their agreements, addressed in Facilitator agreements: employment vs. independent contractor and Non-compete, confidentiality, and employment agreements in the psychedelic industry. Manufacturers protect proprietary cultivation methods and strains in their supply relationships, covered in Vendor and supply agreements for psilocybin manufacturers and labs. A sale of the business runs on confidential due diligence, covered in Closing or transferring a licensed psychedelic business.

What an NDA can protect

An NDA protects information that has commercial value because it is not generally known: cultivation methods, strain genetics, standard operating procedures, pricing, financial records, business plans, and customer or investor lists. For trade-secret information, protection under the law also depends on the owner taking reasonable steps to keep it secret, and a confidentiality agreement is one of those steps. Information loses protection once it becomes public, so an NDA does its work only while the information is still secret and has to be in place before disclosure rather than after.

The standard exclusions and carve-outs

A well-drafted NDA excludes information the receiving party should not be bound to protect: information that was already public, that the receiving party already knew, that it developed independently, or that it rightfully obtained from another source. It also carves out disclosures the law compels. A party served with a subpoena or court order can comply, usually after giving the other side notice and a chance to object. A confidentiality agreement with an employee or contractor should include the notice the Defend Trade Secrets Act requires, which preserves a whistleblower’s immunity for disclosing a trade secret to the government or in a court filing under seal.

What an NDA cannot do

An NDA cannot bar someone from reporting a legal violation to a regulator or law enforcement, cannot prevent testimony the law requires, and cannot obstruct a government investigation. It cannot be used to conceal illegal conduct. An agreement that tries to gag a person from reporting misconduct, a safety problem, or a crime runs against public policy, can be unenforceable in that part, and can create liability for the party that demanded it. A licensing board investigating a facilitator does not lose its access because the parties signed an NDA; What to do if a facilitator crossed ethical or sexual boundaries covers the participant’s side of that.

Business confidentiality is not the same as client confidentiality

The information a center must protect about a participant — their identity, their health history, what happened in a session — is governed by state rule and, where a licensed health professional is involved, possibly by HIPAA. That duty does not come from an NDA, and an NDA cannot substitute for it. What facilitators need to know about client confidentiality and data privacy and HIPAA, state privacy law, and psychedelic client records cover those obligations. The reverse also holds: a center should not ask a participant to sign an NDA that prevents the participant from talking about their own experience or from reporting harm. Confidentiality protects the center’s trade secrets; it does not give the center a tool to keep a participant quiet about what happened to them. An operator who blurs that line invites both an unenforceable agreement and a regulatory problem.

Enforceability and the federal-illegality wrinkle

An NDA is enforced like any contract, which means its scope and duration have to be reasonable, and a court will narrow or refuse an agreement that sweeps too broadly. Because the underlying business is federally illegal, a party resisting enforcement can argue the contract is unenforceable on illegality grounds. Courts have generally been willing to enforce contracts tied to state-legal cannabis and psychedelic operations despite that argument, but the defense exists and the outcome is not uniform. Careful drafting and a clear connection to the state-legal activity reduce the risk.

When public information may be enough

Sample NDAs are widely available, and the general law of trade secrets and confidentiality is well documented. A business can use a standard mutual NDA for a routine exchange of information, such as an early conversation with a potential vendor, and learn the basic exclusions from public sources. The distinctions that need care — the whistleblower carve-outs, the participant-confidentiality line, and the illegality wrinkle — are visible in public legal resources even if drafting around them takes a lawyer.

When you should speak with a lawyer

A lawyer should draft confidentiality terms that protect real trade secrets, that include the carve-outs the law requires, and that do not stray into silencing reports of harm. An operator using NDAs with employees, investors, or supply partners should have the terms fit each relationship rather than reuse one form for all of them. A business that holds proprietary methods worth protecting should have counsel confirm that its confidentiality measures actually support a trade-secret claim, because the protection depends on those steps.

You might also want to read

This article provides general legal information, not legal advice, and does not create an attorney-client relationship. Psychedelic law differs by state and changes over time. Consult a licensed attorney in your jurisdiction before acting on anything described here.